New acne cream shows promise in large chinese trial
NCT ID NCT07186413
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study tests a prescription cream called trifarotene for moderate acne on the face and upper body. About 561 Chinese participants aged 9 and older will apply the cream daily for 12 weeks. The goal is to see if it clears acne better than a cream with no active ingredient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Galderma Research & Development Site #5378
RECRUITINGShanghai, Jing'an District, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.